FA
ABBV icon

FF Advisors’s AbbVie ABBV Stock Holding History

FF Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314K Hold
1,563
– – 0.13% 97
2025
Q4 		$357K Buy
1,563
+2
+0.1% +$456 0.16% 81
2025
Q3 		$361K Buy
1,561
+22
+1% +$4.48K 0.17% 77
2025
Q2 		$286K Buy
1,539
+53
+4% +$9.85K 0.15% 84
2025
Q1 		$280K Hold
1,486
– – 0.16% 77
2024
Q4 		$258K Hold
1,486
– – 0.17% 82
2024
Q3 		$291K Hold
1,486
– – 0.19% 70
2024
Q2 		$255K Hold
1,486
– – 0.18% 78
2024
Q1 		$271K Buy
1,486
+86
+6% +$14.8K 0.19% 74
2023
Q4 		$217K Buy
+1,400
New +$204K 0.18% 76

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FF Advisors's ABBV Position: Q1 2026 in Review

FF Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 1,563 shares worth $314K. The position accounts for 0.13% of the portfolio, ranked #97.

FF Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $361K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FF Advisors held 1,563 shares of AbbVie worth $314K as of Q1 2026.
  • FF Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.13% of FF Advisors's portfolio in Q1 2026, its #97 holding.
  • FF Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • FF Advisors's AbbVie position peaked at $361K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FF Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.